Patent · US Active

Method and means for producing high titer, safe, recombinant lentivirus vectors

US8652837B2 · kind B2 · utility

0Cited by
24References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2007
Grant dateFeb 18, 2014
Priority date
Expiry dateMay 4, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/003
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Lentiviral vectors modified at the 5′ LTR or both the 5′ and 3′ LTR are useful in the production of recombinant lentivirus vectors (See the Figure). Such vectors can be produced in the absence of a functional tat gene. Multiple transformation of the host cell with the vector carrying the transgene enhances virus production. The vectors can contain inducible or conditional promoters.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.